Week 1 (Renal) Flashcards

1
Q

Functions of the kidney

A

Maintain constant ECF volume and content: excrete metabolic waste, adjust urinary excretion of water and electrolytes

Endocrine organ: renin/angiotensin, prostaglandins, bradykinin, erythropoetin, 1,25-dihydroxy vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Determinants of GFR

A

Total GFR = single nephron GFR x nephron mass

snGFR = unit permeability of capillary wall x net pressure gradient (Starling forces) = Kf (ultrafiltration coefficient, which expresses intrinsic permeability of GBM to water) x Puf (mean ultrafiltration pressure across GBM)

snGFR = LpS x (Pgc - Pbs - OPgc)

snGFR = Kf x net filtration pressure

Lp = permeability; S = surface area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Autoregulation of GFR

A

Even when BP (and thus renal artery pressure) changes, GFR stays constant because it is autoregulated

However, angiotensin II is necessary for autoregulation so if you block ATII, GFR is not well autoregulated anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is special about the glomerular capillary?

A

Very high hydraulic permeability

Very large surface area

Very high protein permselectivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of renal failure (loss of GFR)

A

Reduction in total number of glomeruli (normal or supernormal GFR): surgical removal of kidney or some kidney tissue (compensatory hypertrophy and remaining nephrons increase in size and snGFR increases; doesn’t happen after age 40 though), embolism or infarction of kidney tissue, drop out of individual glomeruli due to local glomerular disease (age), interstitial disease (tubular damage followed by glomerular dropout)

Reduction in snGFR (nephron number normal or decreased): reduced renal plasma flow (hemorrhagic/septic/anaphylactic shock), CHF, increased resistance of renal vasculature, impaired autoregulation, increased πgc (myeloma = high plasma protein, dehydration = hemoconcentration), decreased Pgc (ACEi = no constriction of eff art, BP decreased out of autoregulatory zone, NSAIDs inhibit prostaglandin = aff art constriction), increased Pbs (obstruction), decreased LpS (GBM thickened/not permeable due to disease, gentamicin decreases K, glomerular nephritis = inflammatory cells, fibrosis?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical estimation of GFR

A

GFR = UV/P

Ideal filtration marker should be: not protein bound in plasma, freely filtered at GBM, not secreted or reabsorbed, easy to measure, produced endogenously at steady state, not metabolized by any other organ in the body (only the kidney)

Inulin fits all of the above except is not created endogenously and need to infuse IV (not practical!)

Creatinine fits all of the above except 15% is secreted in proximal tubule, so tends to overestimate GFR (due to increased U); also levels depend on age, muscle mass, meat intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alternatives to using creatinine or inulin clearance to measure GFR

A

Cockroft Gault: uses age, weight, sex, FF

MDRD equation: uses sex, race, age, BUN, albumin, FF

Radiolabelled filtration markers: iothalamate, DTPA or EDTA

Cystatin-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BUN

A

Blood urea nitrogen

BUN levels vary inversely with GFR (if BUN high, then GFR low)

Urea production not constant: increased with protein intake/bleeding; decreased by liver disease/malnutrition; increased in CHF (PCT Na and urease reabsorption increased due to low effective plasma volume)

Filtered and reabsorbed (with Na and H2O)

Urea reabosprtion is flow-dependent: more concentrated urine, the more urea is reabsorbed (if dehydrated, will reabsorb more = high BUN in dehydration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does the GBM determine which molecules can and cannot pass?

A

GBM behaves as size and charge discriminating membrane with pores of 4-4.5 nm radius

Water and small molecules (<1.8 nm) pass freely

Macromolecules (>5 nm) do not pass

Albumin (3.6 nm, polyanionic) passes in minute amounts due to negative charge

Barriers to protein passage across GBM: molecular size/shape, negative charge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Congenital nephrotic syndrome: Finnish type

A

Heavy proteinuria in utero

Death in first two years of life

Tx: kidney transplantation

Mutated gene responsible was isolated by positional cloning: NPHS1 (specifically expressed in kidney, mutations segregate with phenotype, encodes the protein nephrin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Minimal change nephrotic syndrome (MCNS)

A

Commonest cause of nephrotic syndrome in children

May occur at any age

Relapsing and remitting course

Often responds dramatically to steroids

Minimal findings on light microscopy and IF

Fusion of podocytes on EM

Rarely causes CKD unless its pathology changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Focal and segmental nephrosclerosis (FSGS)

A

May be specific or non-specific injury pattern

May be primary or secondary (obesity/HIV/drugs)

May be end-stage of MCNS

May cause massive proteinuria

May cause rapid kidney failure in young adults

May recur rapidly in kidney transplant

Putative role of circulating factor (suPAR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Degrees of proteinuria

A

Normally <200 mg/day (mostly tubular)

Microalbuminuria (30-300 mg/day) is abnormal

Proteinuria >300 mg/day: transient (usually benign), orthostatic (often benign), fixed (marker of renal disease)

Heavy proteinuria (>3 g/day) “nephrotic range”

Nephrotic syndrome: edema, hypoalbuminemia, lipidemia, lipiduria, heavy proteinuria (>3g/day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Some causes of nephrotic syndrome

A

Primary glomerulopathies: MCNS, FSGS, MN, MPGN, proliferative GN (IgA nephropathy)

Secondary glomerulopathies: diabetic nephropathy, SLE, plasma cell dyscrasias (myeloma, amyloid), virus infections (hepatitis, HIV), bacterial infections (strep, abscesses), other infections (malaria, amebiasis, syphilis), cancer (paraneoplastic syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What factors determine Puf (mean ultrafiltration pressure across GBM)?

A

Pgc: mean hydrostatic pressure in glomerular capillary (gc); 45mmHg, fairly constant along capillary; determined by balance of resistances of afferent arteriole and efferent arteriole

Pbs: mean hydrostatic pressure within tubule (Bowman’s space); constant at 10-12mmHg

πgc: mean oncotic pressure in glomerular capillary; rises along capillary as plasma is ultrafiltered and protein-free fluid is extracted (leaving more proteins and raising oncotic pressure!)

πbs: oncotic pressure within Bowman’s space; since GBM largely impremeable to protein, is close to 0 and can be ignored

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When does creatinine clearance really badly overestimate GFR?

A

Chronic renal failure: GFR falls and secreted portion accounts for greater percent of urinary excretion

Heavy proteinuria: for unclear reasons, secretion increases and may lead to overestimation of GFR by 100%!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What happens to plasma creatinine when you remove a kidney and why?

A

1) When you remove a kidney, you cut the GFR in half
2) Creatinine filtration (GFR x Pcreat) and excretion (Ucreat x V) are cut in half too because GFR was cut in half
3) Production of creatinine remains the same (still same amount of muscle breakdown), so you’re in positive creatinine balance and plasma cretinine levels rise
4) As Pcreat rises, the creatinine filtration must also rise (since it’s GFR x Pcreat), and does so until creatinine excretion equals production
5) When Pcreat is doubled, the product of GFR x Pcreat is back to normal and new steady state is produced

Note: you’ll always be able to excrete 1500 mg/day because the plasma and thus urine concentration will just be higher!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How are GFR and serum creatinine related?

A

At near-normal levels of renal function, large changes in GFR produce only small changes in serum creatinine

When renal disease is advanced, small changes in GFR will produce large changes in serum creatinine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

BUN:creatinine ratio

A

10 is normal BUN:creatinine ratio

Increased BUN ratio: increased urea production (excess dietary protein, GI bleeding, hemolytic anemia, steroid therapy = protein anabolism), increased urea reabsorption (CHF, dehydration), decreased creatinine production (muscle wasting)

Decreased BUN ratio (less used clinically): decreased urea production (low dietary protein, severe liver disease), increased urea excretion (overhydration), increased creatinine production (muscle breakdown = rhabdomyolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Glomerular permselectivity

A

Size: 5.5 A is too big

Shape: linear, flexible molecules traverse GBM more easily than globular, rigid molecules

Charge: sialic acid is a mucoprotein in the basement membrane that has anionic residues (negative charge) to repel molecules with negative charge; albumin is 3.6 A but cannot pass due to negative charge

Podocin is anionic protein on sides of epithelial foot process and probably helps maintain separation of adjacent foot processes

Nephrin is located at slit diaphragm

In certain glomerular diseases, sialic acid content reduced so more negatively charged molecules can pass (some degree of size discrimination always remains though)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Consequences of loss of charge of GBM

A

1) Proteinuria
2) Fusion of epithelial foot processes
3) Retention of immunoglobulin aggregates (immune complexes) in the mesangium –> can lead to continuous stimulus for mesangial matrix production which could result in glomerular sclerosis and destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Blood flow into and around the nephron

A

Renal artery –> afferent arteriole –> glomerulus –> efferent arteriole –> capillary that supplies rest of nephron?!

Hydrostatic and oncotic pressures in that capillary that runs next to the nephron affects reabsorption from the tubule!

Low BP –> constrict efferent arteriole –> increased pressure in glomerular capillary but decreased pressure in efferent arteriole/capillary –> high oncotic pressure and low hydrostatic in capillary –> more fluid pulled out of PCT and into capillary –> reabsorb more water to increase BP (this shows that when BP down, you keep GFR up by constricting efferent arteriole AND you maintain body fluid by reabsorbing more water by the same mechanism!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Three layers of glomerular capillary

A

Capillary lumen

1) Endothelial cells
2) Glomerular basement membrane (GBM)
3) Podocyte foot processes (part of visceral epithelial cells)

Filtrate in Bowman’s space?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Total body volume and distribution

A

Total body volume (TBV) = 60% of total body weight (TBW)

TBV = 60% intracellular and 40% extracellular (1/3 intravascular and 2/3 interstitial)

Of your total body weight, 60% is is total body volume, 40% is intracellular fluid and 20% is extracellular fluid (60-40-20 rule)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Ions and osmolality in different compartments

A

All compartments have same osmolality (because water follows solute to maintain osmotic equilibrium)

Intracellular: K+, PO4

Extracellular: Na+, Cl-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Effective plasma osmolality

A

Estimated to 2[Na+]

Posm = 280-290

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Effective vs. ineffective solutes

A

Effective solutes contribute to osmolality and osmotic pressures; increase in number of solutes causes free water to move into their compartment; ex: Na+, K+, glucose

Ineffective solutes contribute to osmolality but not to osmotic pressures; can cross vascular walls and cell membranes so water never has to move to follow; ex: urea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Osmoregulation vs. volume regulation

A

Osmoregulation: maintains plasma osmolality (serum [Na+] and cell volume), uses osmoreceptors in hypothalamus to stimulate thirst and ADH, cause urine osmolality and water intake/excretion to change

Volume regulation: maintains effective circulating volume (effective tissue perfusion), uses sensors in carotid sinus (SNS, some ADH), afferent arteriole (RAAS, glomerular perfusion, GFR), and atria/ventricles when severe CHF (ANP when atria stretch/vol exapnds to get RID of water), cause urinary Na+ excretion and thirst

Remember, volume more important than osmolality!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Infusion of isotonic “normal saline”

A

Use volume regulation!

No osmolality change

Increased effective circulating volume (ECV)

Suppression of SNS, ADH, RAAS

Increased ANP to promote Na+ and water excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Free water ingestion

A

Use osmoregulation

Plasma osmolality decreased

Suppress ADH to excrete water

Urine osmolality decreases (more dilute)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Salt ingestion (potato chips with no water!)

A

Use both osmoregulation and volume regulation

Plasma osmolality increased so water shifts extracellularly (into blood vessels/plasma) to increase effective circulating volume (ECV)

Increased ADH, thirst to enhance free water reabsorption and intake which decreases water excretion and increases urine osmolality

Then, RAAS suppressed and ANP increases to cause water excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Sweating in a marathon runner

A

Uses both osmoregulation and volume regulation

Sweat is hypotonic so plasma osmolality increases and ECV decreases

Increased ADH, thirst, RAAS

Decreased ANP

Drink fluid equivalent to sweat composition so no electrolyte/volume disturbances! If drink water, will retain free water and become hyponatremic. If drink nothing, will continue to be hypernatremic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Edema

A

Palpable swelling due to the expansion of interstitial fluid volume

Common clinical conditions associated with edema: CHF, cirrhosis, nephrotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Why don’t you usually get edema?

A

Albumin in the blood maintains oncotic pressure

Lymphatics take away extra fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Edema formation

A

Alteration in more than one of Starling’s forces:

1) increased capillary hydraulic pressure
2) Increased capillary permeability
3) Increased interstitial oncotic pressure
4) Decreased plasma oncotic pressure

Lymphatic obstruction

Renal Na+ and water retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Congestive heart failure causing edema

A

Poor CO –> decreased ECV –> decreased tissue perfusion

Increased RAAS, SNS, ADH –> Na+ and water retention –> increased plasma volume

Early in CHF, this enhances cardiac contractility and CO but as disease progresses, continuing accumulation of plasma volume reaches a point where cardiac contractility cannot be improved to improve CO so Na+ and water retention causes volume expansion and edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Nephrotic syndrome

A

Edema, hypoalbuminemia, heavy proteinuria (>3g/day), hyperlipidemia/hyperlipiduria

Hypoalbuminemia due to urinary loss (and maybe altered albumin metabolism) –> decreased capillary oncotic pressure –> arterial underfilling

Also have renal Na+ retention due to underlying renal disease (independent of hypoalbuminemia)

Increased RAAS, SNS, ADH

Increased capillary permeability (Lp)

Altered reflection coefficient of proteins (s)

Administration of albumin improves renal Na+ excretion and edema (transiently since you’re still losing albumin due to renal disease!) because increases oncotic pressure of plasma so allows you to get rid of water!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Arguments against arterial underfilling due to hypoalbuminemia as sole cause of Na+ retention and edema formation in nephrosis

A

Gradual decrease in plasma albumin would mean gradual decrease in interstitial albumin (why…?) so oncotic pressure gradient would be minimal

People with no albumin don’t have edema!

Correction of renal disease improves Na+ excretion and corrects edema before hypoalbuminemia is corrected!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Ascites and hepatorenal syndrome

A

Happens in patients with cirrhosis

Portal hypertension (due to postsinusoidal obstruction from hepatic fibrosis) causes portosystemic shunt that reduces hepatic metabolism of vasoactive peptides (prostaglandins, substance P, VIP, glucagon all cause vasodilation!) which causes vasodilation of splanchnic bed and systemic circulation (also increased NO increased because reduced clearance of bacterial products and this also contributes)

Fall in systemic ECV and reduced systemic vascular resistance –> Increased RAAS, SNS, ADH to retain water –> heart decompensates and CO decreases –> ascites and edema

Also with SNS, overdo the vasoconstriction in kidneys, brain, liver, adrenals after water IS retained and this causes kidneys to shut down due to severe vasoconstriction (not disease of the kidney, it’s just that blood isn’t going there!) = decreased GFR = hepatorenal syndrome

Note: portal HTN causes splanchnic vasodilation but splanchnic vasodilation makes portal HTN worse because of blood pooling!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Definition of hepatorenal syndrome (HRS)

A

Clinical condition that occurs in patient with chronic liver disease, advanced hepatic failure, and portal HTN characterized by impaired renal function and marked abnormalities in arterial circulation and activity of endogenous vasoactive systems.

In kidney there is marked vasoconstriction that results in low GFR.

In extrarenal circulation there is predominance of arterial vasodilation that results in reduction of total systemic vascular resistance and arterial hypotension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Diagnostic criteria for HRS

A

Cirrhosis with ascites

Serum creatinine >1.5 mg/dl

No improvement of serum Cr after > 2 days with diuretic withdrawal and volume expansion with albumin

Absence of shock

No current or recent nephrotoxic drugs

Absence of parenchymal kidney disease as indicated by proteinuria >500mg/day, microhematuria >50 RBC/hpf, and/or abnormal renal UTZ

Note: if patient improves with infusion of albumin, it is NOT HRS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Subtypes of HRS

A

Type I HRS: > doubling of initial serum creatinine to >2.5 mg/dl or 50% reduction in creatinine clearance to <20 ml/min within 2 weeks; may occur spontaneously but frequently has precipitating factor (severe bacterial infection (SBP), GI hemorrhage, major surgical procedure, or acute hepatitis imposed on cirrhosis); shorter survival of 2 weeks

Type II HRS: moderate and stable reduction in GFR; renal failure does not have rapidly progressive course; dominant clinical feature is severe ascites with poor or no response to diuretics; longer survival of 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Management for HRS

A

Prevention: infuse albumin at dx of SBP; prophylaxis for SBP; use TNF inhibitor pentoxifylline in those with alcoholic hepatitis; avoid nephrotoxic agents/NSAIDs/ overdiuresis/large vol paracentesis

Use albumin to improve intravascular oncotic pressure and mobilize interstitial fluid into central blood volume

TIPS: divert portal blood flow to hepatic vein to systemic circulation; improve variceal bleed; improve renal perfusion; complications are bleeding, infection, hepatic encephalopathy and renal failure (due to dyes?)

Vasoconstrictors: analogues of vasopressin with decreased antidiuretic properties; terlipressin (not in US), octreotide (inhibits glucagon) + midodrine, NE + albumin; sometimes low dose vasopressin

Molecular adsorbent recycling system (MARS): combination of kidney and liver dialysis that has an albumin circuit so can remove albumin-bound toxins and water-soluble toxins (however not yet widely available or approved for tx of chronic liver disease)

Liver transplantation!!

Note: renal vasodilators do not work well!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Hyponatremia

A

[Na+] <136 mEq/L

Most common electrolyte disorder

Independent predictor of death amont ICU and geriatric patients, hear failure acute STEMI, cirrhosis (so need to pay attention to [Na] even though pt might not have symptoms!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Pseudohyponatremia

A

Has nothing to do with total body water or salt imbalance

Falsely high volume: severe hyperlipidemia, hyperparaproteinemia (multiple myeloma, Waldenstrom’s macroglobulinemia)

Extracellular dilution due to extracellular free water shift: hyperglycemia (just give insulin to put glucose in cells!), hypertonic mannitol

Mis-measurement because lots of glucose/mannitol/sorbitol/glycine in blood brings water in but can’t measure those things so looks like hyponatremia

This doesn’t happen anymore!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

True hyponatremia

A

Hypoosmolar state

Hypovolemic: sweat/renal/GI/pulmonary blood loss, third spacing (acute inflammatory state causes increased vascular permeability so intravascular vol shifts out into interstitial space), diuretics (HCTZ), mineralocorticoid insufficiency (cannot reabsorb Na+, cerebral salt wasting

Euvolemic: SIADH, hypothyroidism, cortisol insufficiency, psychogenic polydipsia, tea and toast/beer potomania, reset osmostat, pregnancy, nephrogenic SIAD

Hypervolemic: cirrhosis, nephrotic syndrome, CHF, renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

How do you get either hyper- or hypovolemic hyponatremia?

A

Initially you have low ECV (due to salt and water loss in hypovolemia or due to volume redistribution or vasodilation in hypervolemia), so increase ADH and thirst and drink a ton then get hyponatremic!

Must be able to secrete ADH and must have free water to drink in order to get hypovolemic hyponatremia

Note: looks like just the starting point that is different between hyper- and hypovolemic…mechanism is the same otherwise?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Causes of euvolemic hyponatremia

A

Hypothyroidism: not understood but maybe because CO down, renal plasma flow down so ADH upregulated to retain more water

Cortisol insufficiency: increased CRH which is co-expressed with ADH (just innocent bystander!)

Psychogenic polydipsia: dilution, kidneys can’t get rid of it quickly enough

SIADH: malignancies, drugs affecting CNS (antipsychotics, antidepressants, antiepileptics), CNS problems, pulmonary diseases, N/V, pain, hypoglycemia, NSAIDs, cyclophosphamide

Tea and toast syndrome/beer potomania: don’t eat enough so don’t have enough solute to make urine so can’t get rid of water (kidneys need solute in order to get rid of water)

Pregnancy: drink lots because higher thirst and threshold for ADH release is lower

Nephrogenic SIAD: gain of function mutation of ADH receptor so act like ADH always around!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Urine osmolality and urine Na+ findings in hyponatremia

A

Hypovolemia sweat/renal/GI/pulm/blood loss, third spacing: high urine osmolality, UNa <20

Hypovolemia mineralocorticoid insufficiency, cerebral salt wasting, diuretics: high urine osmolality, UNa >20

Euvolemia SIADH/SIAD, hypothyroid, cortisol insufficiency: high urine osmolality, UNa >40 (pts not retaining salt here!)

Euvolemia psychogenic polydipsia, tea and toast/beer potomania, reset osmostat, pregnancy: low urine osmolality, UNa varies

Hypervolemia cirrhosis, nephrotic syndrome, CHF: high urine osmolality, UNa <20 (trying to hold onto Na+)

Hypervolemia renal failure: urine osmolality similar to serum osmolality (cannot concentrate or dilute well), UNa >20 (cannot reabsorb Na+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Clinical manifestations of hyponatremia

A

Moderate: lethargy, headache, N/V, muscle cramps, restlessness, disorientation, depressed reflexes

Severe: seizures, coma, permanent brain damage, respiratory arrest, brain stem herniation, death

Risks: severity and rate of change, Na>125 usually asymptomatic or minimally symptomatic

51
Q

Osmotic demyelination syndrome (ODS)

A

When you rapidly increase serum [Na] and brain cells shrink and demyelinate

1-2 days: generalized encephalopathy

2-3 days: behavioral changes, cranial nerve palsies, progressive weakness culminating in quadriplegia with locked-in syndrome, possible death

Increased risk: malnourished patients, alcoholics, hypokalemic patients, burn victims, elderly women on thiazides, young menstruant women

Do not call this central pontine myelinolysis (CPM) because happens other places too!

52
Q

Correction of symptomatic hyponatremia

A

5% increase in [Na+] should substantially reduce cerebral edema

Even seizures can be corrected by increase in [Na+] of 3-5 mmol/L

Acute symptomatic: correct at 1-2 mEq/L/hr for 2-3 hours or until neurological symptoms resolve

Chronic: 1/2 mEq/L/hr

Never exceed 8-10 mEq/L/day (use lower range for high risk patients)

53
Q

Therapeutic options for hyponatremia

A

Water restriction in pts that are stable, euvolemic or hypervolemic (don’t want to water restrict someone who is dry!)

Salt supplement with isotonic normal saline in hypovolemic patients; use hypertonic saline in severely symptomatic patients w/severe hyponatremia or SIADH; use salt tablets if euvolemic or if SIADH of malignancy (sad to tell them to water restrict, but good to tell them to eat salty food!)

Increase renal water excretion in patients who aren’t eating make them eat, use vaptans to block vasopressin receptor 2, use furosemide to make dilute urine

Can get hyponatremic encephalopathy if not well oxygenated so make sure patient is oxygenated

54
Q

What conditions can you use AVP (vaptans) for?

A

Euvolemic SIADH, hypothyroidism, cortisol insufficiency

Hypervolemic CHF, nephrotic syndrome, cirrhosis

In any of these conditions, if ADH is secreted too much, use vaptans

Vaptan: V2R antagonist (blocks action of ADH), aka “aquaretics” because get rid of water and not salt

55
Q

Specific treatments for different kinds of hyponatremia

A

Hypovolemic: treat underlying disorder, give normal saline, discontinue HCTZ if applicable

Euvolemic SIADH, hypothyroid, cortisol insufficiency: treat underlying disorder, water restrict, salt suppress if severe

Euvolemic psychogenic polydipsia: water restriction

Euvolemic tea and toast/beer potomania: increase protein intake, consider urea

Euvolemic reset osmostat or pregnancy: leave them alone

Nephrogenic SIAD: same as SIADH except vaptans (won’t help bc this is gain of function mutation)

Hypervolemic: treat underlying disorder, water restriction, vaptans, salt supp if severe hyponatremia and vaptans not available

56
Q

Potential pitralls in causing overcorrection of hyponatremia

A

Miscalculations

Failure to follow serum Na closely (if don’t catch disturbance until the next day it is too late)

Unrecognized sources of Na+ (other MD giving Na+, giving K+ causes Na+ to come out of cells and go into vasculature as if giving Na+!)

Excess free water loss (monitor urine output!): polyuria post pituitary infarction, GC replacement in pts with cortisol insufficiency, pts with central DI not taking ddAVP, excessive GI or skin hypotonic fluid loss, recovery from acute respiratory failure, withdrawal of thiazides during correction of hyponatremia, water deprivation in primary polydipsia, volume expansion with IV fluids

57
Q

Problem with treating SIADH with normal saline infusion

A

Patient with SIADH has Uosm of 600

Give 1L of 300mM salt but kidneys want to concentrate urine (so much ADH around)

Kidney takes 300mosmol salt and 500ml water to create 600mosm urine! Then have 500ml free water left to reabsorb!

In the end it’s like you’re giving 500ml free water and making the problem worse!

Make sure osm of fluid is higher than osmolality of urine or else this will happen!

58
Q

How does K+ administration cause Na+ to shift out of cells in intravascularly?

A

K+ into cells and Na+ out

K+ into cells and H+ out, but H+ does not contribute to osm because buffered, so water follows K+ into cells, decreasing intravascular volume

K+ and Cl- into cells, and again water follows K+ into cells, decreasing intravascular volume

If patient hyponatremic and hypokalemic, don’t give 200 Na+, give 150 Na+ and 50 K+

59
Q

Types of polyuria

A

Water diuresis: nephrogenic DI, central DI, psychogenic polydipsia, pregnancy (vasopressinase in placenta degrades ADH!)

Solute diuresis: urea, glucose TPN, contrast dye, myoglobin, hemoglobin, mannitol, IV fluids

60
Q

When do you get hypernatremia?

A

One of these 3 problems and inadequate free water replacement or thirst defect:

1) Excessive administration of Na+: NG feeding without adequate free water, normal saline replacement for hypotonic fluid loss, alkalinization of IV fluids (1 amp bicarb contains 45mEq Na!)
2) Free water loss: burn patient/GI/sweat loss of hypotonic fluid, nursing home/debilitate patient, DI + problem with free water access/thirst center, osmotic diuresis (TPN, glucose, urea, mannitol, diuretics, contrast dye)
3) Intracellular free water shift: rhabdomyolysis, seizures

61
Q

Treatment for hypernatremia

A

If impending cardiovascular collapse use normal saline

If past +/- ongoing salt loss, use D5 1/4 NS, or D5 1/2 NS

If need excess glucose, use D10W

If water deprived nursing home/debilitated patient, use D5W, D5 1/4 NS (NEVER free water alone!)

62
Q

Categories of kidney injury

A

Acute kidney injury: sudden decrease in GFR over hours or days

Rapidly progressive renal failure: renal fxn declines weeks to months

Chronic kidney disease: renal fxn declines >3 months

63
Q

How to diagnose acute kidney injury

A

Presents as increase in serum BUN and creatinine and/or reduction in urine volume

Ongoing research of biomarkers but not ready for day to day clinical practice yet (most likely will be urine tests like KIM-1, NGAL)

Summary: most commonly diagnosed by change in BUN and/or serum creatinine (look at time course of change and if baseline creatinine not known, use clinical judgment); change in urine volume important mostly for defining prognosis but sometimes may be first manifestation of disease

64
Q

Azotemia vs. uremia

A

Azotemia: increase in circulating concentrations of waste products/nitrogenous substances (viz. urea nitrogen, creatinine)

Uremia: syndrome of signs and symptoms associated with renal dysfunction

Every patient with uremia has azotemia, but most patients with azotemia are not uremic

65
Q

RIFLE criteria minimum thresholds for acute kidney injury diagnosis

A

Risk of renal injury: creatinine 1.5x baseline, urine output <0.5 ml/kg/h for >6 hr

Injury to kidney: creatinine 2x baseline, urine output <0.5 mg/kg/h for >12 hr

Failure of kidney function: creatinine 3x baseline or >4mg/dl with increase >0.5 mg/dl, urine output <0.3 ml/kg/h for >24 hr or anuria for >12 hr

Loss of kidney function: persistent renal failure for >4 weeks

End-stage disease: persistent renal failure for >3 months

Other definitions: risk involves increase serum creatinine of 0.3-0.5 mg/dl over baseline

AKI is first 3 categories (“RIF”)

66
Q

How do we diagnose kidney disease if we don’t know baseline serum creatinine?

A

Duration of renal dysfunction: pre-existing lab data, inpatient or outpatient

Anemia implies chronic kidney disease (no erythropoietin!): normocytic, normochromic anemia in the absence of any other cause of anemia

Kidney size: small kidneys specific for chronic kidney disease, normal sized kidneys can occur with either acute kidney injury or chronic kidney disease

Radiologic evidence for renal osteodystrophy or significant PTH elevation implies CKD

Greater the tolerance of azotemia, longer the time the patient has had kidney disease

67
Q

What can interfere with creatinine secretion?

A

Drugs: trimethoprim, cimetidine inhibit the secretion of creatinine

68
Q

Urine volume in AKI diagnosis

A

Urine volume <0.5 ml/kg/h considered to be reduced

Severity of AKI can be determined by presence/absence of oliguria (urine output <400 ml/day) or anuria (urine output <100 ml/day)

Prognosis of oliguric AKI (chance of recovery or death) is substantially worse than of non-oliguric AKI

Note: if urine volume less than 500, won’t be able to stay in fluid balance and will build up fluids

69
Q

3 types of causes of AKI

A

Pre-renal: GFR falls due to inadequate renal perfusion (kidneys perceive low volume so produce less urine to maintain intravascular volume)

Intrinsic renal/renal parenchymal: involving glomeruli, tubules, interstitum, or blood vessels in renal parenchyma

Post-renal: mechanical obstruction to normal flow of urine from kidneys to ureters to bladder and finally through urethra

70
Q

Pre-renal acute kidney injury

A

Hallmark is true or perceived decrease in perfusion to the kidneys

Causes include:

Hypovolemia: volume loss (GI, renal, skin), blood loss (GI, MVA)

Cardiac causes: acute cardiogenic shock, CHF

Liver disease: could be excessive diuretic use, GI bleeding causing vol depletion, hepato-renal syndrome, acute tubular necrosis

Nephrotic syndrome: ineffective intra-arterial volume and not a direct result of underlying disease

Renovascular: renal venous thrombosis

71
Q

Intrinsic/parenchymal renal AKI

A

SIte of injury is glomerulus, tubulointerstitum, or intra-renal vasculature

Glomerulus: acute glomerulunephritis

Tubulointerstitial: acute tubular necrosis (ATN), acute tubulointerstitial nephritis, intra-tubular crystal deposition

Vascular: vasogenic, microangiopathic hemolytic anemia (MAHA), cholesterol emboli

72
Q

Acute tubular necrosis (ATN)

A

Most common renal parenchymal disease that leads to AKI

Ischemic ATN: causes that lead to pre-renal disease cause ischemic ATN if severe enough or go on for long enough

Toxic ATN: caused by radiocontrast dye, aminoglycosides, amphotericin B, cis-platinum, endogenous myoglobin (after crush injury) and hemoglobin (after intravascular hemolysis)

On histology, see loss of brush border, some mitotic figures as cells divide and try to restore themselves

After ischemia and reperfusion, lose brush border, lose polarity, then cells undergo apoptosis and necrosis and obstruct lumen and cause backleak of tubular fluid

73
Q

Acute interstitial nephritis

A

Form of parenchymal AKI caused by allergic reaction to administered medication (usually for 5 days or longer)

Most commonly caused by beta lactam antibiotics (penicillins, cephalosporins), PPIs, NSAIDs, H2 blockers

Renal dysfunction may be associated with fever or other systemic symptoms (rash, etc)

See eosinophiluria (>5%)

74
Q

Intratubular obstruction

A

Parenchymal AKI caused by precipitation of some sort of crystals

Immunoglobulins/light chains in patients with multiple myeloma

Calcium in patients with hypercalcemia

Uric acid in people with tumor-lysis syndrome

Drug crystals in patients receiving acyclovir, indinavir, sulphadiazine

Oxalate in people who have consumed ethylene glycol or vitamin C

75
Q

Vasogenic/Functional AKI

A

Can be classified as pre-renal or parenchymal

Functional disorder (reversed by stopping medication) due to change in vascular tone

Medication-induced AKI: NSAIDs cause inhibition of prostaglandins which leads to constriction of afferent arteriole which decreases GFR; ACEi and ARBs inhibit ATII which leads to dilation of efferent arteriole which also decreases GFR

Also cyclosporine/FK506 and hypercalcemia constrict afferent arteriole?

76
Q

Post-renal AKI

A

Obstruction to urine flow leading to backup of fluid in bladder or in kidney

Obstruction must be bilateral, or unilateral in setting of underlying chronic kidney disease or single functioning kidney

Do US to see if buildup of urine

77
Q

Key tests in virtually all cases of AKI

A

Urine analysis incuding microscopy

Urine electrolytes

Renal ultrasonography

Renal biopsy if suspect acute glomerulonephritis (rare to do this now though)

78
Q

Urine analysis in AKI

A

Specific gravity tells you how concentrated the urine is

Dipstick measures albumin, blood, leukocytes/nitrate

Microscopy shows you cells (RBCs, WBCs), casts, crystals

79
Q

Active urine sediment

A

Implies acute glomerulonephritis

Active urine sediment: glomerular hematuria (dysmorphic RBCs, RBC casts), generally associated with proteinuria

Only way to get red cells in urine is via glomerulus so must be problem with glomerulus causing AKI

80
Q

WBC casts in the setting of AKI

A

In setting of AKI and sterile pyuria, implies tubulointerstitial nephritis

WBCs present if there is some sort of inflammation

Most common cause is acute pyelonephritis (bacteria), but drugs too??

81
Q

Urine sediment in pre-renal AKI

A

Remember, usually no intrinsic damage to kidney yet

Generally benign

May see hyaline casts (but not sensitive or specific for any type of AKI)

82
Q

Urine sediment in ATN

A

Epithelial cell casts

Muddy brown casts

This is rare, and occurs when tubule itself is undergoing necrosis

83
Q

Interpretation of urine chemistry in pre-renal (incl HRS) vs. intrinsic renal

A

Pre-renal (incl HRS): urine vol decreased, sp gr >1.02, Uosm >500, FENa <1%, FEurea <35%, FEuric acid <7%, urine sediment has hyaline casts

Intrinsic renal: variable urine volume, sp gr 1.01, Uosm <350, FENa >2%, FEurea >35%, FEuric acid >15%, other urine sediment

84
Q

Fractional excretion of sodium

A

FENa is percentage of filtered sodium that is excreted

In health (normal GFR): <1-2%

Pre-renal: <1%

Intrinsic renal >2%

FENa = [(UNa/PNa)/(UCr/PCr)] x 100 = [(UNa/UCr)/(PNa/PCr)] x 100

Considerations: urine volume (oliguric/non-oliguric) because normal FENa = pre-renal FENa!, false + FENa, diuretics (use FEurea instead because diuretics tell you not to reabsorb Na+)

85
Q

Role for kidney biopsy

A

For overwhelming majority of clinical settings, decision making about distinction of acute vs. chronic, and potential causes is made on clinical grounds

Rarely used to diagnose AKI

Renal biopsy imperative in presence of urine sediment

Know someone has glomerulonephritis but want to know how to treat it?

86
Q

Clinical course of AKI

A

Specifically ATN:

Initiation: don’t get BUN/creatinine increase until after time of injury; creatinine, eGFR poorly related to actual renal function

Maintenance

Recovery: may be polyuric

Time course generally lasts 3-10 days, may be up to 12 weeks

87
Q

Principles of management of AKI

A

Correct underlying disease if possible: improve renal perfusion (give fluids or improve cardiac function) if pre-renal, relieve obstruction if post-renal, give steroids +/- cytotoxics for glomerulonephritis

If ATN or underlying causes not treatable, treatment is supportive: monitor fluids to prevent volume overload, manage metabolic complications, avoid nephrotoxics, know when to dialyze!

Agents to prevent or ameliorate course of parenchymal AKI have not been effective

88
Q

What urinalysis reveals

A

Unremarkable: pre-renal AKI

RBCs in urine, dysmorphic: glomerulonephritis

Granular casts, epithelial casts, cellular debris: ATN

WBCs/WBC casts: pyelonephritis, interstitial nephritis (if WBCs are eosinophils) or glomerulonephritis

Eosinophiluria: allergic interstitial nephritis or cholesterol emboli

Muddy brown casts: acute tubular necrosis (ATN)

89
Q

When do dialyze in AKI?

A

Absolute indications for dialysis: CHF despite diuretics, unable to medically manage hyperkalemia and metabolic acidosis, pericarditis, encephalopathy, signs/symptoms (severe volume overload where you need intubation or O2, etc..?)

AEIOU: acidosis, electrolytes (hyperkalemia), ingestion/intoxication, overload of fluid, uremia

Dialyze BEFORE any of these complications develop though (waiting for appearance of these is unacceptable!)

90
Q

Prognosis of AKI

A

Occurrence of AKI increases death risk in patients with multi-organ failure in the ICU, in-hospital mortality may approach 80%

In patients who survive, renal function recovers in most, but even if serum creatinine normalizes, there is underlying scarring and GFR does not normalize

Also patients who survive are at higher risk for subsequent development of chronic kidney disease and end-stage renal disease

Prevention is always better but not always possible

91
Q

What are the most common kinds of AKI?

A

Pre-renal azotemia and ATN comprise up to 80% of all causes of AKI

Need to distinguish between pre-renal azotemia and ATN!

92
Q

Glomerular components from outermost in

A

Parietal epithelial cells of Bowman’s capsule (protect us from outside world!)

Bowman’s space (this is outside environment!)

Visceral epithelial cells (contain podocytes/foot processes that partially cover BM and spaces btwn are bridged by slit diaphragms)

Basement membrane (is outside of either endothelial cells of capillary or mesangial cells)

Endothelial cells (fenestrated)

Capillary lumen

Note: mesangial cells are inthe middle, contacting either BM or endothelial cells at all times

93
Q

Mesangium

A

Support the capillaries and endothelial cells

Like stroma (support), modified smooth muscle cells/pericytes

Consists of matrix and mesangial cells

Mesangium contiguous with media of arterioles

Mesangial matrix material is similar to basement membrane material (both stain silver!)

Mesangial cells have contractile function, phagocytic, proliferate, secrete biologic mediators, produce mesangial matrix

94
Q

What cells do the endothelial cells contact?

A

In the glomerulus, endothelium is only partially surrounded by mesangium

Where mesangium is absent, the endothelium is surrounded by glomerular basement membrane

So, endothelium supported by either mesangium or basement membrane

95
Q

Subepithelial vs. subendothelial immune deposits

A

Subepithelial deposits: between epithelial cells (which have podocytes) and BM; usually have less inflammation; are father out toward Bowman’s capsule

Subendothelial deposits: between endothelial cell (fenestrated, right by capillary lumen) and BM; usually have more inflammation; closer in toward capillary lumen

96
Q

Glomerular basement membrane (GBM)

A

Collagen Type IV (forms a network to which other proteins attach: laminin, proteoglycans, fibronectin)

6 different collagen IV alpha chains which combine in various forms to produce collagen Type IV triple helices (building blocks of GBM)

97
Q

Slit diaphragm

A

Composed primarily of nephrin a transmembrane protein whose extracellular portion extends between the foot processes but intracellular portion connects to podocin, CD2AP, and actin cytoskeleton

This whole thing is one unit and comprises part of the cytoskeleton

98
Q

Terminology for glomerular disease

A

Focal: involving <50% of glomeruli

Diffuse: involving >50% of glomeruli

Segmental: involving a portion of a glomerulus

Global: involving most of a glomerulus

99
Q

Histologic alterations of glomeruli

A

Hypercellularity (used to be called proliferation)

BM thickening or duplication

Sclerosis: closure of capillary loops, solidification

Hyalinosis: insudates of plasma proteins that become trapped in areas of scarring; glassy, pink eosinophilic stuff

Crescents: cellular proliferation in Bowman’s space (macrophages, neutrophils, epithelial cells, fibrin); usually due to BM rupture; seen in severe glomerular injury

100
Q

Pathogenesis of glomerular injury

A

1) In situ antibody antigen reactions (antibody against intrinsic glomerular antigen or against planted antigen (that got into glomerulus from elsewhere)): Type II hypersensitivity reaction
2) Deposition of circulating antibody antigen complexes: Type III hypersensitivity reaction
3) Cytotoxic antibodies
4) Cell mediated immunity
5) Soluble mediators (complement, cytokines, etc)

101
Q

Detection of immune complex deposits

A

Use immunofluorescence to detect and characterize (IgG, IgA, IgM, C3, etc)

Use EM for precise localization of deposits (subepithelial vs. subendothelial)

102
Q

How long do circulating immune complexes cause problems for?

A

If process of forming ICs is transient then deposits are phagocytized and/or degraded; inflammatory changes resulting from deposits resolve –> patient gets better

If process is continuous, disease is chronic and get progressive glomerulonephritis –> dialysis, death or transplantation

103
Q

5 major clinical syndromes of glomerular disease

A

Nephrotic syndrome

Acute nephritic syndrome

Rapidly progressive glomerulonephritis (RPGN)

Asymptomatic hematuria and proteinuria

Chronic renal failure

104
Q

Nephritic vs. nephrotic syndrome

A

Nephritic: inflammatory process (variable combo of neutrophils, lymphocytes and macrophages in capillary loops); hematuria (capillary wall injury), RBC casts, azotemia, oliguria, hypertension, mild proteinuria (<3.5g/day)

Nephrotic: edema, hypoalbuminemia, hyperlipidemia/hyperlipiduria, massive proteinuria (>3.5g/day)

Note: in nephrotic syndrome, the holes in the podocytes allow proteins to go through and leak out, but don’t allow cells to go through, so no RBCs in nephrotic syndrome!

105
Q

Membranous nephropathy

A

Nephrotic syndrome

Most common cause of nephrotic syndrome in adult caucasians

Antibody reaction to antigens located on epithelial cells (Type II): Ags may be intrinsic to epithelium (phospholipase A2 receptor on visceral epithelial cell = primary/idiopathic) or planted on epithelial cell after crossing BM (bacterial or viral antigens (syphilis, schistosomiasis, malaria, Hep B, rarely Hep C), malignancy (lung, colon, breast, melanoma), rheumatic disease (lupus, scleroderma), inorganic salt (gold), some drugs (captopril, penicillamine))

Subepithelial deposits, then with progression get segmental and global sclerosis

LM: thickened GBM (epithelial cells respond to injury by making more BM); see “stubble” because BM spikes are dark and deposits are light

IF: granular deposits of IgG and complement along BM

EM: “spike and dome” appearance of new BM with spikes (podocytes) forming between subepithelial deposits

Prognosis: variable course, proteinuria in 60%, progressive renal disease in 40%, renal failure in 2-20 years

106
Q

Minimal change nephropathy

A

Nephrotic syndrome

Most common cause of proteinuria in children, but can occur at any age

Lipoproteins in urine, follows viral infection, associated with Hodgkin’s lymphoma

LM: normal glomeruli

EM: foot process effacement

IF: negative

Tx: steroids (don’t need to take biopsy to treat)

107
Q

Focal segmental glomerulosclerosis (FSGS)

A

Nephrotic syndrome

More common in AA and hispanic, risk is obesity

Hematuria and hypertension usually seen

Can be primary (idiopathic) or secondary as a component of glomerular ablation nephropathy (nephron loss leading to hyperfiltration of remaining glomeruli) or congenital (mutation in nephrin or podocin), or secondary to other glomerular diseases; soluble mediator in serum has been identified

FSGS recurs after transplantation in 10-20%, can recur within 24-48 hours, recurrence rate higher in patients who had aggressive disease in native kidney

IF: negative, no ICs

EM: negative, no ICs

Prognosis: 50% of patients in renal failure in 10 years

Tx: prevent recurrence after transplantation with aggressive plasmapheresis (get rid of soluble mediator)

108
Q

Membranoproliferative glomerulonephritis (MPGN) Type I

A

AKA mesangiocapillary GN

Usually nephrotic but can present as mixed nephrotic and nephritic

Pathogenesis: ICs from serum sickness, deposits can trigger/fix complement, recruit inflammatory cells

Mesangial proliferation (reaction to deposits) and capillary wall abnormalities –> large glomeruli, “lobular accentuation” of glomerular tuft, hypercellular

Thickening of capillary walls due to massive subendothelial deposits

Double contoured (“tram-track”) capillary walls due to migration of mesangium into capillary wall in reponse to subendothelial deposits

Can be primary (idiopathic): IgG and complement deposits; more common in children

Can be secondary due to infections (infected shunts, Hep B, Hep C) or lupus: IgG and any combination of IgA, IgM, and complement; more common in adults

IF: granular deposits along loops and in mesangium

Prognosis: 30-40% progres to chronic renal failure

109
Q

Membranoproliferative glomerulonephritis (MPGN) Type II

A

AKA dense deposit disease (DDD)

Similar presentation to idiopathic (Type I) MPGN: nephrotic or mixed

In children and young adults; not associated with hepatitis or bacterial infections or lupus; not associated with circulating ICs

Pathogenesis: activation of alternate complement pathway; mutations in complement components, Abs which interfere with various complement components resulting in inappropriate activation, anti-complement factor H or B; in children usually mutation in complement and in adults usually autoantibody

BM thickened by ribbon-like deposits; complement present in irregular granular and linear distribution, variable mesangial cell proliferation and inflammatory cell component

Difference from Type I is that get intramembranous very dense IC deposits in BM

Decreased serum C3 but normal C1 and C4

110
Q

Acute proliferative glomerulonephritis

A

Nephritic syndrome

IC deposits trapped in glomerulus (bind/fix complement, leukocytic infiltration, proliferation of mesangial, endothelial and epithelial cells) that can be caused by exogenous antigens (post-infectious/poststreptococcal) or endogenous antigens (lupus)

Poststreptococcal GN is one type

Can also get it from staphylococcus, Hep B, plasmodium (malaria), treponema (syphilis)

111
Q

Poststreptococcal glomerulonephritis

A

Nephritic syndrome

Type of acute proliferative glomerulonephritis

Group A (Strep pyogenes) beta hemolytic strep (strains 12, 4, 1)

1-4 weeks following skin or pharyngeal infection (latent period correlates with time required for production of antibodies against strep organism)

Diffuse global GN and glomeruli full of neutrophils (swollen endothelium, occasionally segmental fibrinoid necrosis, rarely see crescents)

IgG and complement on capillary walls and in mesangium; starry sky pattern (less uniform than in membranous nephropathy); subepithelial lumpy-bumpy pattern plus some subendothelial and mesangial deposits on EM

Prognosis: most children recover but 15-50% of adults develop end stage renal disease; deposits resolve within a few months, no scarring in most cases, biopsy not performed if diagnosis certain

112
Q

IgA nephropathy (Berger’s Disease)

A

Nephritic syndrome

Most common primary glomerular disease worldwide; more common in Asian and hispanic but uncommon in AA

Often follows URI or GI infection; most present with hematuria or proteinuria; 10% present with nephrotic syndrome

Related to Henoch Schonlein purpura

Pathogenesis: IgA Ab/Ag complexes trapped in mesangium; abnormal IgA production and clearance (increased IgA production in bone marrow); only 50% have increased serum levels of IgA; increased incidence in twins; increased incidence with celiac disease and liver disease (liver can’t clear IgA Ab/Ag complexes from intestines); abnormal glycosylation may reduce plasma clearance of IgA

LM: mesangial proliferation, segmental sclerosis, crescents

IF: mesangial deposits

EM: deposits, mesangial matrix (both under BM but in mesangial cell, so not called subendothelial)

Prognosis: 25-30% develop renal failure over 20 years; rarely aggressive

113
Q

Henoch Schonlein purpura

A

Systemic IgA syndrome due to IgA deposition in multiple organs

Skin: purpuric rash

GI: abdominal pain, bloody diarrhea

Joints: arthritis

Kidney: IgA nephropathy

Note: cannot diagnose Henoch Schonlein purpura by kidney biopsy–need to look at entire patient and see IgA vasculitis elsewhere

114
Q

Alport syndrome (hereditary glomerulonephritis)

A

Nephritic syndrome

Mutation in Type IV collagen causes glomerulonephritis, deafness and eye problems

Variable inheritence; mutations in alpha 3, 4, 5 chains of collagen Type IV; X-linked, AR or AD inheritance

Variability in collagen deletion leads to variability in clinical presentation/severity

LM: variable and nonspecific; progressive glomerular sclerosis

IF: negative

EM: alternately thick and thin BMs; thick areas have irregular lamination of lamina densa (“basket weave” pattern)

115
Q

Thin basement membrane nephropathy

A

Nephritic syndrome

Some siblings of Alport’s patients have this (in others it is sporadic); females in families with X-linked disease

Non-progressive microscopic hematuria only

116
Q

Rapidly progressive glomerulonephritis (RPGN)

A

Nephritic syndrome

A clinical syndrome (rapidly deteriorating renal function over days to weeks) and if untreated have irreversible loss of renal function

Various causes/disease associations: Goodpasture’s syndrome, Wegener’s granulomatosis, microscopic polyangitis

LM and IF: all (>50%) glomeruli have crescents (severe glomerular injury almost always due to ruptured capillary loop BMs, contain fibrin in Bowman’s space, macrophages, epithelial cells, and plasma proteins like C3b; may see platelets walling off ruptured BM)

Note: if disease is not rapidly progressive (so not classified as RPGN) then just presents with nephritic syndrome

117
Q

3 groups of crescentic GN

A

1) Anti-GBM disease (10-15%): Goodpasture’s syndrome (linear IgG deposits on capillary walls by IF but not EM, tx with plasmapheresis to remove pathogenic Ab)
2) Circulating immune complex mediated disease (45%): IgA (Henoch Schonlein purpura), MPGN, lupus, postinfectious, rarely membranous nephropathy; plasmapheresis does not help
3) Pauci-immune (45%): nothing seen on IF; most patients have +ANCA (microscopic polyangitis = pANCA/anti-MPO; Wegener’s granulomatosis = cANCA/anti-proteinase 3)

118
Q

Why is it that when you have extensive loss of nephrons, you progress to ESRD?

A

1) Focal segmental glomerulosclerosis (FSGS): as nephrons die, the surviving ones have to work harder and become damaged; compensatory hypertrophy, increased blood flow/filtration/transcapillary pressure, injury to endothelial and epithelial cells, protein accumulation in mesangium –> triggers proliferative and inflammatory mediators which cause injury to epithelium –> proteinuria; segmental scarring and eventually global scarring –> decreased GFR –> vicious cycle
2) Tubular atrophy and interstitial fibrosis: glomerular scarring causes scarring of tubules because efferent arteriole cannot supply blood to tubulointerstitum so causes ischemia and inflammation and scarring –> inflammation induces fibrosis and that entraps next tubule over –> tubule scarring causes sclerosis of the upstream glomeruli –> severe proteinuria and vicious cycle

119
Q

What 3 conditions is low C3 associated with?

A

1) Post-infectious GN
2) Lupus
3) Membranoproliferative glomerulonephritis (MPGN)

Note: lots of things that cause GN do not have low C3, but if you DO find low C3, must be one of these

120
Q

Treatment for AFR due to ATN caused by myoglobinuria

A

Alkalinize urine to solubilize myoglobin

Mannitol and saline to enhance excretion of myoglobin

Keep patient hydrated to flush out myoglobin

Obtain urine electrolytes prior to treatment to provide insight into diagnosis

Diuretics and dye studies (nephrotoxicity) contraindicated

121
Q

Hemolytic uremic syndrome

A

Triad:

1) Microangiopathic hemolytic anemia
2) Thrombocytopenia (low platelets)
3) AKI (uremia)

122
Q

Things that increase/decrease BUN:creatinine ratio

A

Muscle wasting and cachexia: decreased creatinine production –> increases ratio

Rhabdomyolysis: spills creatinine into the blood –> decreases ratio

Dehydration: induces urea reabsorption –> increases ratio

High dietary protein: increases BUN –> increases ratio

GI bleeding: increases urea production as RBCs are broken down in the intestine –> increases ratio

Liver disease –> decreased urea production because no urea cycle –> decreases ratio

123
Q

Kidney injury caused by NSAIDs and ACEIs

A

NSAIDs: block effect of prostaglandins, constricting afferent arteriole to decrease GFR; acute interstitial nephritis (AIN), nephrotic syndrome, renal papillary necrosis

ACEIs: block effect of angiotensin II, dilating efferent arteriole to decrease GFR; acute interstitial nephritis (AIN), membranous glomerulonephropathy, immune complex glomerulonephritis, acute tubular necrosis

If taking both ACEI then NSAID, can develop pre-renal azotemia because very low GFR!